{"id":4531,"date":"2018-05-23T15:05:39","date_gmt":"2018-05-23T06:05:39","guid":{"rendered":"https:\/\/www.3rockconsulting.com\/wordpress\/?p=4531"},"modified":"2019-05-10T15:06:53","modified_gmt":"2019-05-10T06:06:53","slug":"20180523","status":"publish","type":"post","link":"https:\/\/www.3rockconsulting.com\/en\/news\/20180523\/","title":{"rendered":"Jeff Schnack featured on Podcast"},"content":{"rendered":"<p>Jeffrey Schnack talked with Valeocon Management Consulting about the pharmaceutical commercial model in Japan, and how it is evolving through emerging regulations and market changes.<\/p>\n<p><a href=\"https:\/\/www.valeocon.com\/pharma-commercial-model-in-japan\/\" rel=\"noopener noreferrer\" target=\"_blank\"><img decoding=\"async\" loading=\"lazy\" src=\"\/uploads_e\/2018\/05\/JeffonValeocon-e1527065441202.png\" alt=\"\" width=\"600\" height=\"338\" class=\"alignnone size-full wp-image-1333\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Jeffrey Schnack talked with Valeocon Management Consulting about the pharmaceutical commercial model in Japan, and how it is evolving through emerging regulations and market changes.<\/p>\n","protected":false},"author":1,"featured_media":3629,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_locale":"en_US","_original_post":"3628"},"categories":[8,3],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/posts\/4531"}],"collection":[{"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/comments?post=4531"}],"version-history":[{"count":0,"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/posts\/4531\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/media\/3629"}],"wp:attachment":[{"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/media?parent=4531"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/categories?post=4531"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.3rockconsulting.com\/wp-json\/wp\/v2\/tags?post=4531"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}